From mint · Pranati Deva · · 1m 10s
Godavari Biorefineries Shares Jump 15% on US Patent
Godavari Biorefineries shares surge 15% after US cancer treatment patent grant.
In brief
Godavari Biorefineries shares surge 15% after US cancer treatment patent grant. Godavari Biorefineries shares rose 14.8% intraday after US patent for cancer treatment compounds was granted. Originally reported by mint.
Godavari Biorefineries Shares Jump
Godavari Biorefineries shares rose as much as 14.8% after the company said a US patent for compounds intended to treat cancer had been granted.
“5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER”
Trading Volumes Surge
Trading volume surged to more than 132 times its weekly average.
Patent Details
The patent protects a novel class of compounds that effectively inhibit cancer and cancer stem cells.
Volume Comparison
The stock recorded a volume of 71,54,965 shares on Thursday, compared with an average of 54,038 shares over the past week.
Price Performance
Godavari Biorefineries shares climbed as much as 14.8% to an intraday high of ₹ 262 apiece.
Market Context
The stock remains 26% below its 52-week high of ₹ 353.50, recorded in April 2025.
Q1 Results
Godavari Biorefineries reported a wider net loss of ₹ 19.3 crore in Q1 FY27, compared with a loss of ₹ 16 crore in the previous fiscal year.
The essence
Godavari Biorefineries shares rose 14.8% intraday after US patent for cancer treatment compounds was granted.
